Tenaya therapeutics to participate in upcoming october investor and industry conferences

South san francisco, calif., sept. 29, 2022 (globe newswire) -- tenaya therapeutics, inc. (nasdaq: tnya), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, announced today that faraz ali, chief executive officer, is scheduled to participate in the chardan 6th annual genetic medicines conference and the alliance for regenerative medicine's cell and gene meeting on the mesa. details of participation are as follows:
TNYA Ratings Summary
TNYA Quant Ranking